Lukasz Dzialach

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Spontaneous remission of Cushing disease after clinically silent pituitary apoplexy with persistent positive desmopressin stimulation.

Spontaneous remission of Cushing disease after clinically silent pituitary apoplexy with persistent positive desmopressin stimulation.

Journal: Polish archives of internal medicine

Published: September 08, 2026

Osilodrostat for the treatment of Cushing syndrome: an update.

Osilodrostat for the treatment of Cushing syndrome: an update.

Journal: Expert review of endocrinology & metabolism

Published: February 20, 2026

Analysis of the effect of recombinant human growth hormone therapy on metabolic parameters in patients with severe growth hormone deficiency in adulthood.

Analysis of the effect of recombinant human growth hormone therapy on metabolic parameters in patients with severe growth hormone deficiency in adulthood.

Journal: Endokrynologia Polska

Published: December 29, 2025

Thrombolysis-induced pituitary tumor apoplexy: a rare neuroendocrine complication of peripheral arterial revascularization.

Thrombolysis-induced pituitary tumor apoplexy: a rare neuroendocrine complication of peripheral arterial revascularization.

Journal: Endokrynologia Polska

Published: December 22, 2025

Successful non-surgical treatment of bilateral macronodular adrenocortical disease with osilodrostat.

Successful non-surgical treatment of bilateral macronodular adrenocortical disease with osilodrostat.

Journal: Endokrynologia Polska

Published: June 19, 2025

Prolonged adrenal suppression after osilodrostat discontinuation in a patient with Cushing's disease with eventual hypercortisolism relapse: Case Report and literature review.

Prolonged adrenal suppression after osilodrostat discontinuation in a patient with Cushing's disease with eventual hypercortisolism relapse: Case Report and literature review.

Journal: Frontiers in medicine

Published: May 15, 2025

Real-World Experience with Pasireotide-LAR in Cushing's Disease: Single-Center 12-Month Observational Study.

Real-World Experience with Pasireotide-LAR in Cushing's Disease: Single-Center 12-Month Observational Study.

Journal: Journal of clinical medicine

Published: March 04, 2025

Is there still a place for etomidate in the management of Cushing's syndrome? The experience of a single center of low-dose etomidate and combined etomidate-osilodrostat treatment in severe hypercortisolemia.

Is there still a place for etomidate in the management of Cushing's syndrome? The experience of a single center of low-dose etomidate and combined etomidate-osilodrostat treatment in severe hypercortisolemia.

Journal: Endocrine

Published: August 14, 2024

Critical illness-related corticosteroid insufficiency (CIRCI) - an overview of pathogenesis, clinical presentation and management.

Critical illness-related corticosteroid insufficiency (CIRCI) - an overview of pathogenesis, clinical presentation and management.

Journal: Frontiers in endocrinology

Published: July 30, 2024

Case report: A challenging case of severe Cushing's syndrome in the course of metastatic thymic neuroendocrine carcinoma with a synchronous adrenal tumor.

Case report: A challenging case of severe Cushing's syndrome in the course of metastatic thymic neuroendocrine carcinoma with a synchronous adrenal tumor.

Journal: Frontiers in endocrinology

Published: March 12, 2024

Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.

Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.

Journal: Frontiers in endocrinology

Published: November 14, 2023

Cushing's Disease: Long-Term Effectiveness and Safety of Osilodrostat in a Polish Group of Patients with Persistent Hypercortisolemia in the Experience of a Single Center.

Cushing's Disease: Long-Term Effectiveness and Safety of Osilodrostat in a Polish Group of Patients with Persistent Hypercortisolemia in the Experience of a Single Center.

Journal: Biomedicines

Published: November 02, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026